Profilo
Dr. Rebecca Pruss is Chief Scientific Officer at Trophos SA. Dr. Pruss was previously employed as Head-Exploratory Research by Sanofi-Synthelabo Canada, Inc.
Precedenti posizioni note di Rebecca Pruss
| Società | Posizione | Fine |
|---|---|---|
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Direttore Tecnico/Scientifico/R&S | 01/10/2015 |
| Sanofi-Synthelabo Canada, Inc. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Health Technology |
| Sanofi-Synthelabo Canada, Inc. |
- Borsa valori
- Insiders
- Rebecca Pruss
